Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-30T23:37:32.639Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine Rechallenge after an Episode of ‘Neuroleptic Malignant Syndrome’

Published online by Cambridge University Press:  02 January 2018

Michael Weller  and
Johannes Kornhuber
Michael Weller
Affiliation:
Clinical Neuroscience Branch, Building 10, Room 3N256, Bethesda, MD 20892, USA
Johannes Kornhuber*
Affiliation:
University of Würzburg, Füchsleinstraße 15, 8700 Würzburg, Germany
*
∗Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

Nine out of 4044 patients admitted to our institution between 1987 and 1990 suffered an episode of NMS. Neuroleptic rechallenge using clozapine for persisting psychiatric illness was tolerated by eight patients. Clozapine was discontinued in one older, high-risk patient because recurrence of NMS was anticipated. Clozapine should be considered a drug of choice for psychotic patients with a history of NMS.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 161 , Issue 6 , December 1992 , pp. 855 - 856
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Addonizio, G., Susman, V. L. & Roth, S. D. (1987) Neuroleptic malignant syndrome: review and analysis of 115 cases. Biological Psychiatry, 22, 1004–1020.CrossRefGoogle ScholarPubMed
Adityanjee (1991) Clozapine in patients with NMS. British Journal of Psychiatry, 159, 294.CrossRefGoogle Scholar
Burrell, M. F., Fewster, C., Szabadi, E., et al (1991) Clozapine-treated NMS. British Journal of Psychiatry, 158, 577.Google Scholar
Levenson, J. L. (1985) Neuroleptic malignant syndrome. American Journal of Psychiatry, 142, 1137–1145.Google Scholar
Müller, T., Becker, T. & Fritze, J. (1988) Neuroleptic malignant syndrome after clozapine plus carbarnazepine. Lancet, 2, 1500.Google Scholar
Pope, H. G., Keck, P. E. & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Rosebush, P. I., Stewart, T. D. & Gelenberg, A. J. (1989) Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry, 50, 295–298.Google Scholar
Shalev, A. & Munitz, H. (1986) The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatrica Scandinavica, 73, 337–347.CrossRefGoogle ScholarPubMed
Susman, V. L. & Addonizio, G. (1988) Recurrence of neuroleptic malignant syndrome. Journal of Nervous and Mental Disease, 176, 234–241.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.